The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mitchell David Chilton since 2015.
The trader's CIK number is 1627684.
At the time of the last reporting, Mitchell David Chilton was the VP Global Regulatory & Quality of Neoleukin Therapeutics, Inc.. (stock ticker symbol NLTX).
Also see all insider trading activities at Neoleukin Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | AQXP | 5,175 | $102,646 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-08-24 | AQXP | Buy | 3,575 | 17.81 | 63,670 |
| 2015-08-11 | AQXP | Buy | 1,600 | 24.36 | 38,976 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mitchell David Chilton (VP Global Regulatory & Quality of Neoleukin Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.